Doctor Whose Drug Killed Teen Returns as Gene Tech Booms Again

July 30, 2015

(Bloomberg) – Gelsinger’s death, in 1999, sent the fledgling field of gene therapy into a decade-long funk in the U.S. Almost overnight, an area with seemingly limitless medical and commercial promise was tainted. Which is why what is happening now might seem so surprising. After years of worry and doubt, gene therapy — in effect, using genes as medicine — is exploding across the white-hot biotech scene. And at the center of it all is none other than James Wilson.